Table 1.
MM patient characteristics.
| Characteristic | AutoGVHD Number (n = 8) |
Non-autoGVHD Number (n = 16) |
|---|---|---|
| Age, years | ||
| Mean ± SD | 60 ± 5.3 | 62.1 ± 7.8 |
| Range | 51–66 | 42–71 |
| Sex | ||
| % male | 62.5 | 37.5 |
| Race, number | ||
| Caucasian | 7 | 15 |
| African American | 0 | 1 |
| Hispanic | 1 | 0 |
| Mobilization, number | ||
| G | 0 | 2 |
| DTPACE + G | 1 | 1 |
| BDTPACE + G | 3 | 5 |
| MBDTPACE + G | 3 | 5 |
| DTPACE + pegG/DA | 1 | 0 |
| BDTPACE + PL + G | 0 | 3 |
| Autologous HPC transplant, number | ||
| Mean ± SD | 2.1 ± 0.8 | 1.6 ± 0.7 |
A: adriamycin; B: bortezomib; C: cyclophosphamide; D: dexamethasone; DA: darbepoetin alfa; E: etoposide; G: granulocyte-colony stimulating factor; M: melphalan; P: cisplatin; PL: plerixafor; SD: standard deviation; T: thalidomide.